Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $26,079 - $31,191
-2,595 Reduced 19.61%
10,636 $113,000
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $21,728 - $26,085
-1,928 Reduced 12.72%
13,231 $157,000
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $7,875 - $9,743
-898 Reduced 5.59%
15,159 $164,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $96,494 - $114,203
-10,062 Reduced 38.52%
16,057 $158,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $1,587 - $1,811
-176 Reduced 0.67%
26,119 $260,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $16,201 - $21,589
-1,761 Reduced 6.28%
26,295 $252,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $16,367 - $21,698
-1,877 Reduced 6.27%
28,056 $312,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $7,267 - $9,538
857 Added 2.95%
29,933 $255,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $141,916 - $175,007
-14,263 Reduced 32.91%
29,076 $304,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $132,376 - $207,807
13,494 Added 45.21%
43,339 $471,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $35,472 - $43,071
-2,934 Reduced 8.95%
29,845 $403,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $33,681 - $38,460
-2,542 Reduced 7.2%
32,779 $444,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $7,483 - $9,318
-577 Reduced 1.61%
35,321 $504,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $1.01 Million - $1.38 Million
-74,401 Reduced 67.45%
35,898 $501,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $1.58 Million - $2.07 Million
110,299 New
110,299 $2.07 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.